Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:11:40.527Z.
Calculation as of: 2026-10-06T14:11:40.527Z.
Quote observation: 2026-10-06T14:04:50.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
DarioHealth Corp.
Market Cap
$45.37M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$45.18M
Operating Cash Flow Yield
N/A
TTM Avg
11.87%
3Y Avg
9.02%
5Y Avg
6.85%
Market Cap
$45.19M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$47.47M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.04M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $45.37M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $45.18M | N/A | 11.87% | 9.02% | 6.85% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.19M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.20M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.04M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $42.46M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $48.94M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
